Case study 4 of 5 · Decided by accountability
Four specialty programs on one routing architecture
I put four specialty-care programs (Surgery, Everyday Urgent Care, Behavioral Health, and Oncology Care) on one shared system instead of four custom ones, so nurses and navigators worked from the same facts and every case had a named owner.
Context
High-acuity specialty cases (Surgery, Oncology, Behavioral Health) were stalling in exception queues, limiting how fast programs could deploy across employer partners. The challenge was scaling four clinical domains at once — each with different protocols, benefit structures, and partner integrations — without building four separate products. 1 BusinessWire
The decision
I built one shared system instead of a product per program: routing rules that assigned every case to a clinical role, so all four programs ran on one architecture. I stated the trade up front: slower to build, faster to scale.
A product per program Not chosen
Four builds, one per specialty, each carrying its own protocols, benefit structures, and partner integrations. Ships the first program soonest, but no one has to agree across clinical teams on who owns a case.
One shared decision infrastructure Chosen
A unified member record and role-based routing under all four programs. Slower to stand up, and forces four clinical teams to agree on who is responsible for a case at each step.
Stated at the time as a trade: slower to build, faster to scale. Four programs launched on one shared architecture, and routing delays stopped being the primary bottleneck.
| Program | Acuity and protocol | Partner integration | What the shared routing decides |
|---|---|---|---|
| Surgery | High-acuity; its own protocols, benefit structure, and compliance requirements | — | Which clinical role owns the case, and when an exception escalates |
| Oncology | High-acuity; its own protocols, benefit structure, and compliance requirements | Healthwise clinical content in CancerCare v1; second opinions handed to the nurse line through the vendor Consumer Medical | Which clinical role owns the case, and when an exception escalates |
| Behavioral Health | High-acuity; its own protocols, benefit structure, and compliance requirements | — | Which clinical role owns the case, and when an exception escalates |
| Everyday Urgent Care | Everyday acuity, unlike the three above; its own protocols, benefit structure, and compliance requirements | — | Which clinical role owns the case, and when an exception escalates |
What happened
I designed shared member records and tied routing rules to clinical roles, with exception handling and escalation behind them. I also led the Cancer & Decision Support pod, which shipped CancerCare v1: a symptom-checking triage tool with Healthwise content and an in-app second-opinion flow that handed off automatically to the nurse line through Consumer Medical. It inferred a care pathway from reported symptoms for adults and children, and every path ended with a named clinical role, not with the tool; dashboards showed exceptions as they happened.
Four specialty-care programs launched on shared infrastructure. Routing-related delays dropped as a primary bottleneck, and the gap between the best and worst service lines narrowed.
What I’d keep
One system can carry many programs once every decision point has a named owner. Assigning that owner is the architecture.
It is the Epic escalation path at a larger scale: there, one route for regulatory changes; here, a route for every case in four programs. I carried the pattern into Andwise as a founder, and learned there that a product good enough to be adopted still does not settle who will pay for it.
Sources
1 Oncology Care launch
Transcarent launched Oncology Care during this specialty-care product period.
The launch announcement, on BusinessWire.
The four-program launch on shared infrastructure, the drop in routing delays, and the narrowing between the best- and worst-performing service lines all come from my records; Transcarent has published none of them. The source above covers the public Oncology Care launch only.
Revised